Philips Once Again Recognized as a Top 100 Global Innovator
- Details
- Category: Philips
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has again been named a Derwent Top 100 Global Innovator by Clarivate Analytics. Clarivate Analytics' Top 100 Global Innovators Report identifies the world's most innovative organizations, assessing each one on its ability to successfully develop valuable patented inventions that also have strong commercialization potential based on
Clinical Study Confirms Effectiveness of CardioSecur® in Pre-Clinical Deployment in Ambulances
- Details
- Category: Industry
The study "CardioSecur® in the preclinical setting - When time does matter" of the University of Heidelberg confirms the advantages of the mobile ECG in acute cases. This was demonstrated by applying CardioSecur during a period of more than 7 months in ambulances in the area of Heidelberg, Germany.
BIOTRONIK Announces First Enrollment in CRT-Next Study
- Details
- Category: Industry
BIOTRONIK has announced first enrollment in a multicenter study that aims to demonstrate that a two-lead cardiac resynchronization therapy (CRT) system with atrial sensing is at least as effective as a conventional three-lead system. BIOTRONIK's CRT-DX technology provides therapy through two ventricular leads and features a floating dipole for complete atrial diagnostics without an additional lead.
NHS Transformation Professionals Team Up to Help UK Hospitals with Improvement Ambitions
- Details
- Category: Industry
A network of NHS transformation professionals has launched to support NHS and private healthcare providers in improving the safety, effectiveness and experience of care. Called Transforming Healthcare Consultancy (THC), the team of individual specialists will provide health service improvement, change management and digital transformation services.
Merck and Tencent Announce Collaboration on Intelligent Digital Healthcare Services in China
- Details
- Category: Industry
Merck, a leading science and technology company, signed a strategic collaboration agreement with Tencent, a leading provider of Internet value added services. The collaboration will primarily focus on increasing public disease awareness and providing more accessible healthcare services via digital platforms in China, by leveraging the company's scientific leadership and expertise combined with Tencent's leading technology in the fields of internet and artificial intelligence.
Final Report: Provision of a Market Study on Telemedicine
- Details
- Category: Download
The aim of the study is to examine the telemedicine market in Europe and to understand the factors that determine its development. The analysis maps telemedicine applications and solutions, and applicable technical standards and guidelines; it also describes market dynamics and potential barriers limiting wider deployment and uptake of telemedicine solutions. Finally, the study assesses the cost-effectiveness of larger-scale deployment of telemedicine under current and future market conditions, to provide policy makers with advice and considerations for wider deployment of telemedicine.
First EU Citizens Using ePrescriptions in other EU Country
- Details
- Category: Development
The first EU patients can use digital prescriptions issued by their home doctor when visiting a pharmacy in another EU country: Finnish patients are now able to go to a pharmacy in Estonia and retrieve medicine prescribed electronically by their doctor in Finland.
The NHS Long Term Plan: Cracking the Da Vinci Code?
- Details
- Category: Opinion
Opinion Article by Prof. Michael Thick, Chief Medical Officer, Chief Clinical Information Officer, IMS MAXIMSReading the NHS Long Term Plan this week, I had a definite sense of déjà vu. And that's not just because we have seen similar plans in the past.
We have, of course, but this plan is still of interest and welcome. I think everybody would be very surprised if itwere to last ten-years, but it’s good to have a clearly articulated vision for the service and where the technology should go.
Open Access Drug Development Tools Feature in New IMI Call for Proposals
- Details
- Category: Open Calls
New open access tools for drug development, obesity, and the environmental impacts of medicines are the focus of a new IMI2 Call for proposals launched today. The total budget of the Call is over EUR 80 million. Half of this comes from the European Commission's Horizon 2020 programme and will fund the participation in the projects of universities, small and medium-sized companies, patient groups etc.
Applications Now Open for Pioneering Digital Health Accelerator Programme
- Details
- Category: Industry